ASX-Dividend-Report-Banner

NaoTrac Robot Pioneers Robotic Neurosurgery in Bolivia with Successful Brain Tumor Biopsies

November 13, 2024 11:10 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 NaoTrac Robot Pioneers Robotic Neurosurgery in Bolivia with Successful Brain Tumor Biopsies
Image source: Kalkine Media

HSINCHU, Nov. 13, 2024 /PRNewswire/ -- On November 5, 2024, Bolivia marked a historic moment in neurosurgery at Hospital Arcoiris, where two successful brain tumor biopsy surgeries were conducted using NaoTrac, the world's first autonomous surgical navigation robot. These groundbreaking surgeries, led by experienced neurosurgeon Dr.Mirko Mantilla, achieved precise and safe extraction of biopsy tissue, offering new hope for faster recovery and improved patient outcomes across Bolivia. Dr. Mantilla expressed optimism about the impact of NaoTrac in the region: "Having NaoTrac here is a game-changer. It will greatly enhance recovery and help countless patients in need."

Dr. Mirko Mantilla performed the first neurosurgery with assistance from NaoTrac at Hospital Arcoiris in Bolivia.
Dr. Mirko Mantilla performed the first neurosurgery with assistance from NaoTrac at Hospital Arcoiris in Bolivia.

Hospital Arcoiris is leading the way in making world-class medical care accessible to all Bolivians. Through the pioneering social surgery program, the hospital is proud to offer cutting-edge neurosurgical procedures using the NaoTrac robotic system at minimal or no cost, especially for underserved communities. This initiative reflects the unwavering dedication to improving the lives of those in need, ensuring that advanced healthcare technology is within reach for everyone. The surgeries are part of a broader collaboration between Brain Navi and Hospital Arcoiris to bring advanced neurosurgical procedures—including stroke treatment, neuroendoscopy, deep brain stimulation, and stereotactic EEG—to Bolivia.

Nelson Farfan Espada, Brain Navi's Managing Director for Latin America collaborated closely with the distributor ICERLAB S.R.L. and Hospital Arcoiris to make this groundbreaking initiative a reality. Reflecting on the journey, he shared, "After a challenging yet deeply rewarding process, I believe this program will truly benefit the people of Bolivia. By embracing the latest advancements in precision medicine, we are giving Bolivians access to world-class medical care and the opportunity for healthier, brighter futures.

About Brain Navi

Brain Navi Biotechnology, a leading Taiwanese surgical robotic company, specializes in designing and developing innovative navigation and robotic surgery technologies. Their proprietary Surface Mapping Auto-Registration Technology (SMART) represents a significant surgical breakthrough, integrating machine vision, robotics, and artificial recognition for streamlined surgical procedures and real-time imaging, ensuring minimal invasive outcomes. NaoTrac's swift patient registration and automatic surgical instrument registration enable surgeons to plan trajectories effortlessly, and the robot ensures precise autonomous navigation toward the desired target.

About Hospital Arcoiris

A non-profit healthcare institution in La Paz, Bolivia, the hospital is dedicated to providing high-quality medical care to underserved and vulnerable communities. Founded to serve those in need, the hospital offers a comprehensive range of medical services, from specialized care to community outreach programs, including mobile clinics and telemedicine.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.